BY THE DIGITAL HEALTH LEADERS FOR THE DIGITAL HEALTH COMMUNITY
BY THE DIGITAL HEALTH LEADERS 
DoP Allocates INR 243 Cr for Establishing Centers of Excellence in NIPERs July 3, 2024 The steering committee approved CoE proposals from all National Institute of Pharmaceutical Education and Research (NIPERs) and sanctioned a budget of INR 700 Cr for the next five years.
60 Small Drug Makers Join Pharma Tech Upgrade Scheme Facing Quality Concerns July 3, 2024 This move aims to enhance drug production standards and restore confidence in Indian pharmaceutical products globally.
Pharma MSMEs to Benefit from Revamped PTUAS, Says DoP Secretary Chawla July 2, 2024 In a significant development for India's pharmaceutical MSMEs, the revamped Pharmaceutical Technology Upgradation Assistance Scheme (PTUAS) is set to usher in substantial transformations, revealed Department of Pharmaceuticals (DoP) secretary Dr Arunish Chawla.
Rajesh M Patel Becomes New CEO of AGD Biomedicals July 1, 2024 Mumbai-based AGD Biomedicals has appointed Rajesh M Patel as its new CEO. The company develops and manufactures quality medical devices and diagnostics.
Emcure Pharmaceuticals to Launch IPO on July 3 June 28, 2024 Bain Capital-backed Emcure Pharmaceuticals is set to launch its Initial Public Offering (IPO) on July 3, 2024.
Government to Overhaul Drug Pricing Committee Amid Industry Pushback June 27, 2024 Reportedly, the proposed changes come after numerous complaints from pharma associations about the current pricing framework.
IISc Develops Advanced 3D Hydrogel Culture System to Study Tuberculosis Infection June 26, 2024 This breakthrough allows for a detailed study of Mycobacterium tuberculosis (Mtb), the bacteria responsible for tuberculosis (TB). Additionally, by mimicking the mammalian lung environment, this system offers a new method for investigating TB infection and assessing the efficacy of TB treatments.
DoP Expands Committee Responsible for Drugs & Medical Devices Pricing Reform June 25, 2024 Initially formed in March this year, the committee's scope has broadened to include representatives from major pharmacy trade organizations, healthcare service providers, and doctors' associations, as well as various patient advocacy groups. Let us know what’s the scope of work of this expansion
Majority of SLAs did not Submit NSQ Data in May: CDSCO June 24, 2024 As per the latest Central Drugs Standard Control Organisation (CDSCO) report, a significant number of State Licensing Authorities (SLAs) have failed to submit monthly data on Not of Standard Quality (NSQ) drugs despite repeated directives from the Central Licensing Authority (CLA).
Sun Pharma Partners with Takeda to Introduce Gastrointestinal Drug in India June 24, 2024 Sun Pharmaceutical Industries, a major player in the Indian pharmaceutical sector, has joined forces with Japan's Takeda Pharmaceutical Company.
Emcure Pharma Receives SEBI Nod for INR 800 Cr IPO June 21, 2024 According to Emcure Pharmaceuticals, the capital generated from the fresh issue will be allocated towards debt repayment and general corporate purposes.
Indian Pharma Industry to Reach $130 Bn Size by 2030: Report June 20, 2024 The study reveals that the United States emerges as the largest buyer of Indian pharmaceuticals, accounting for almost 30% of these exports.
